Oncology

Fruquintinib promising agent for advanced NSCLC

FROM JOURNAL OF CLINICAL ONCOLOGY Investigational agent fruquintinib holds promise as a third- or ...

Outpatient CAR T infusions feasible using liso-cel

REPORTING FROM THE 2018 BMT TANDEM MEETINGS SALT LAKE CITY (FRONTLINE MEDICAL NEWS) – ...

Cancer groups offer guidance on immune-related adverse events

The American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) ...

TFR achievable with second-line nilotinib for chronic CML

FROM ANNALS OF INTERNAL MEDICINE Second-line nilotinib may lead to maintained molecular response and ...

Best options for treating relapsed/refractory PTCL

EXPERT ANALYSIS FROM TCLF 2018 LA JOLLA, CALIF. (FRONTLINE MEDICAL NEWS) – When patients ...

Radiation offers no survival benefit in early lung cancer with positive margins

FROM THE JOURNAL OF SURGICAL RESEARCH For patients with early-stage non–small-cell lung cancer (NSCLC) ...

Breast cancer care delayed when patients have high deductibles

FROM JOURNAL OF CLINICAL ONCOLOGY High-deductible health insurance plans may be bad for women’s ...